Introduction
Halogenopteridines (1) are an interesting group of . reactive synthons which are widely used in synthetic approaches due to easy nucleophilic displacement reactions. The pteridine nucleus offers an unique structure regarding the fact that each ring carbon atom is located adjacent to a least one ring nitrogen atom functioning as an activator of the carbon center and attached halo-atoms. There are gradual differences in reactivity of the halogeno atoms, where the aminolysis of chloropteridines is concerned (2, 3) in the positional order 7 > 6 > 4 > 2 and in presence of powerful electron-donating substituents such reactions are expectedly progressively impeded according to the number of such deactivating groups present. We have recently shown (4) that the same reactivity pattern is also valid in the 1,3-dimethyllumazine series due to a much stronger activation of the 7-chloro over the 6-chloro atom by the additional mesomeric interaction of the 4-carbonyl function creating obviously a vinylogous acid chloride type molecule in the former case and
The high reactivity of 7-chloro-l ,3-dimethyllumazine (1) can best be seen from nucleophilic displacement reactions with various amines. Allylamine, piperidine, morpholine and piperazine react in methanol at room temperature in high yields to give the corresponding 7-subst. amino derivatives 2-5. The sterically more hindered benzhydrylamine and the weaker nucleophile aniline required boiling in the same solvent for several hours, whereas a reaction with 1-adamantylamine could only be achieved in a fusion process of both components at 210°C leading to 7-(1-adamantylamino )-1 ,3-dimethyllumazine (7) .
Analogous reactions with 6-chloro-1,3-dimethyllumazine (18) as a substrate proceeded only under more drastic conditions and in general with lower yields to the corresponding 6-lumazinamines 12 -17. The synthesis of the third substrate, 6,7-dichloro-1,3-dimethyllumazine (19) (5), was improved by forming first 6,7 -dihydroxy-1 ,3-dimethyllumazine from 5,6-diamino-l,3-dimethyluracil and oxalic acid in boiling DMF to give a clean material in 65% yield followed by chlorination with a POCI 3 /PCI s mixture at 80-90°C for 3 days. On gentle work-up 19 was obtained in the form of nicely colourless crystals in 68% yield . 19 was then treated with ammonia and a large number of primary and secondary amines to give on stirring in methanol or dioxane at room temperature or slightly elevated temperature the expected monosubstitution of the more reactive 7-chloro atom with formation of 20-34. Hydrazine, phenylhydrazine, ethyl hydrazidocarboxylate and sodium azide reacted analogously to give 38 -41 as do also the heterocycles imidazole, pyrazole, and 1,2,4-triazole to give the corresponding azolides 3S -37 in reasonable yields.
The introduction of an electron-donating substituent in the 7-position of 19 decreases the reactivity of the 6-chloro atom towards nucleophilic displacement reaction even further, which allowed a disubstitution only under more severe reaction conditions. 6-Chloro-1,3-dimethyl-7-lumazinamine (20) for example could not be converted into 1 ,3-dimethyl-6, 7-lumazinediamine by cone. ammonia, methanolic ammonia, liquid ammonia, potassium amide, ammonia in formamide, ammonia in acetamide or ammonium chloride Pteridines ! Vol. 1 / 1989 / NO. 3 in cone. aqueous ammonia in an autoclave at temperatures ranging from 80 -180 cC. This result is surprising to some extent, since 2,3-dichloro-quinoxaline is claimed to react with liquid ammonia at 90 "C in 95.5% yield to give 2,3-quinoxalinediamine (6) . The reaction of 20 with the stronger nucleophile methylamine in N-methylformamide and in presence of methylammonium chloride at 170 . C. however, proceeded well and gave the 6-methylamino-1,3-dimethyl-7-lumazinamine (42) in 80% yield. The analogous synthesis of 6-dimethylamino-l ,3-dimethyl-7-lumazinamine (43) worked best by boiling 20 in DMF for 20 h, whereas piperidine afforded the substitution to give 44 after reflux for 8 h. In a similar manner the piperidino residue has been introduced into 7-~ hydroxyethylamino-(22), 7-morpholino-(33), 7-piperidino- (32) , and 7-carboethoxymethylamino-6-chloro-l ,3-dimethyllumazine (23) to form the diamino derivatives 4S -48, whereby in the latter case the ester function reacted simultaneously to form the corresponding amide (46) . The 6,7-bis-benzylamino-l,3-dimethyllumazine (49) was obtained by three different pathways. Boiling in benzylamine converted 19, 27 and 20 into 49, indicating that in the latter case also a transamination reaction took place. A most interesting reaction was observed on boiling of various 7-subst. amino-6-chlorolumazine derivatives in morpholine. 6,7-Dichloro-1,3-dimethyllumazine (19) and 6-chloro-7 -morpholino-l ,3-dimethyllumazine (33) led on reflux for 24 h to a mixture of the expected 6,7-ogenation seems to be of general nature, since 6-dimorpholino-1,3-dimethyllumazine (50) and by an chloro-7 -piperidino-l ,3-dimethyllumazine (32) is also unusual dehalogenation reaction also to the monotransformed into a mixture of 6-morpholino-7-pipersubsti tuted 7-morpholino derivative (4) . This deha lidino-(51) and 7-piperidino-l ,3-dimethyllumazine(3), whereas with 6-chloro-7-benzylamino-(27), 6-chloro-7-dimethylamino (29) , and 6-chloro-7-pyrrolidino-1 ,3-dimethyllumazine (31) the corresponding 7-monosubstitution products , 10, and 11 could easily be isolated in about 40% yield after 12 h of reflux in neat morpholine.
UV jVIS: Uvikon 820, Kontron and Perkin Elmer, Lambda 5, spectrometer; "'max in nm (lg c). IH-NMR:
The characterization of the newly synthesized compounds was achieved by elemental analysis, pK determinations in various cases as well as UV and IH_ NMR spectra.
Pteridines / Vol. 1 / 1989 / No.3 Bruker WM-250 and Jeol JNM-MH 100 in 8 (ppm) relative to TMS. TLC: precoated silica-gel thin-layer sheets F 1500 LS 254 and cellulose thin-layer sheets F 1440 LS 254 from Schleicher & Schull. M. p.: Buchi apparatus, model Dr. Tottoli; no corrections. pK de-terminations were done by the spectrophotometric method (7).
7-Allylamino-I,3-dimethyllumazine (2)
In 25 ml of MeOH are suspended 1.0 g (4.4 mmol) 7-chloro-l,3-dimethyllumazine (1) (4), then 1 g of allylamine added and the mixture stirred at room temperature for 1 h. It is concentrated to half of the volume, the precipitate (1.0 g; 91 %) collected and purified by recrystallization from 130 ml of n-BuOH to give 0.77 g (77%) of colourless crystals of m. p. 300°C (decomp. 
1,3-Dimethy l-7-piperidino-lumazine (3)
In 100 ml of MeOH are stirred at room temp. 2.2 g (9.7 mmol) of 1 (4) and 2 ml of piperidine for 5 h. The precipita te (2.3 g; 86%) is filtered off and recrystallized from 160 ml of isopropanol /charcoal to give 1.9 g (71 %) of colourless crystals of m . 
1,3-Dimethyl-7-morpholinolumazine (4)
In 500 ml of MeOH are stirred at room temp. 7.0 g (31 mmol) of 1 and 7 g of morpholine for 30 min. The precipitate (7.6 g; 89%) is fitered off and purified by recrystallization from 200 ml of EtOH to give 6.9 g (80%) of colourless crystals of m. 
7-( I-Adamantyl)-amino-I,3-dimethyllumazine (7)
A mixture of 6 g (26.5 mmol) of 1 and 9.0 g (60 mmol) of 1-adamantylamine is heated in an oilbath to 210 "C for 3 min . After cooling the melt is treated with little EtOH and filtered. RecrystalIization from 140 ml of n-BuOH gave 7.6 g (84%) of colourless crystals of m. p. 289-291 "C. 
7-Anilino-I,3-dimethyllumazine (8)
In 50 ml of MeOH are stirred 1.0 g (4.4 mmol) of 1 and 1 ml of aniline at room temperature for 16 h. The precipitate (1.1 g; 88%) is collected and recrystallized from n-BuOH and CHCI 3 to give 0.7 g (56 %) of yellowish crystal powder ofm . p. > 310 cC (decomp. (10) In 4 ml of morpholine are heated 0.15 g (0.56 mmol) of 29 to 110°C for 12 h. After cooling 30 ml of ether is added and a precipitate separated slowly. The crystals are collected and gave on recrystallization from EtOH (10 ml) 0.065 g (49%) colorless crystals ofm . p. 8.00 (s, 1 H, H-C(6»; 3.37 (s, 3H, CH3N); 3.23 (s, 3H, CH3N); 3.18 (s, 6H, (CH3hN).
1,3-Dimethyl-7-py rrolidinolumazine (11)
a) A solution of 0.226 g (1 mmol) of 1 in 10 ml
MeOH was treated with 0,3 ml ofpyrrolidine with stirring for 30 min. The precipitate was filtered off and gave on recrystallization from EtOH 0.2 g (77%) of colorless crystals of m. p. 238 "C. 3-dimethyllumazine (12) In a mixture of 20 ml MeOH and 10 ml of CHCl 3 are heated 1.0 g (4.4 mmol) of 18 and 1 ml of allylamine under reflux for 30 min. The precipitate was collected after cooling to give 0.72 g (66%) of yellowish crystals of m. p. 242 -244°C. 
6-Benhydrylamino-I,3-dimethyflumazine (16)
A mixture of 0.5 g (2 .2 mmol) of 18 and 5 ml (29 mmol) of benzhydrylamine were heated to 130°C for 5 days. After cooling was diluted with 200 ml of CHCl 3 and then washed with 100 ml of IN HC!. The CHCl 3 layer was separated, dried over Na2S04, filtered and evaporated to dryness. The residue was dissolved in toluene, put onto a silica-gel column (17) A mixture of 0.5 g (2.2 mmol) of 18 and 1 g (6.6 mmol) of 1-adamantylamine was well grinded and then heated to 200 D C for 15 h. The melt was treated after cooling with CHCb and H~O. The CHCI 3 layer was dried over Na2S04, filtered and evaporated. The residue was dissolved in toluene and put onto a silicagel column (17 x 3.5 cm) for chromatography with a gradient of toluene/ EtOAc 9: 1 ---+ 5 : 1. The product fraction was evaporated and the residue gave on recrystallization from EtOH 0 . 
6-( l-Adamanty l) -amino-l ,3-dimethyllwnazine
In a mixture of 250 ml of POCI) and 40 g of PCIs are heated to 80 -· 90 G C for 3 d ays 109 (41.4 mmol) of 6, 7-dihydroxy-l ,3-dimethyllumazine (8) . The excess of POCl 3 was distilled off in vacuum and the residue is hydrolysed by addition of ice and stirring. The solution was then extracted with CHCl} (3 x 120 ml), the organic layer dried over Na2S04, filte red and evaporated. The resulting solid was recrystallized from 100 ml of EtOH to give 7.3 g (68%) of yellowish crystals of m . p. 153 nc. Lit. (5) m. p. 151 -152 "c.
The material was chromatographically a nd spectroscopically identical with an authentic sample.
General procedure for the synthesis of 7-subst. amino-6-chloro-I,3-dimethyllumazines
In 20 ml of dioxane or methanol were stirred at room temperature 0 .65 g (2.5 mmol) of 6,7-dichloro-1 ,3-dimethyllumazine (19) with the appropriate amine 139 component. The reaction product was collected by suction and gave colorless crystals on recrystallization (Table 3) . In a few cases (26, 28, 30) boiling under reflux was more effective . (41) In 50 ml of toluene were heated 0.65 g (2 .5 mmol) of 19 and 0 .325 g (5 mmol) of NaN 3 to 70 "c for 15 h with stirring. The mixture was evaporated to dryness, the residue treated with H 2 0 and then acidified to pH 4. The precipitate was collected and gave on recrystallization from MeOH (50 ml (42) In 15 ml of N-methylformamide were heated 1.0 g (4.14 mmol) of 20, 2 g of methylammonium chloride and 3 ml of methylamine under reflux for 6 h. A precipitate separated on cooling (0.78 g). Recrystallization from 30 (44) In 20 ml of piperidine were heated 0.43 g (1.8 mmol) of 20 under reflux for 8 h. The precipitate was collected after cooling and gave on recrystallization from (46) In 40 ml of piperidine were heated 0. (47) In 10 ml of piperidine were heated 0. (50) In 20 ml of morpho line were heated 0.65 g (2.5 mmol) of 19 to 100°C for 24 h. The precipitate, consisting of two compounds, was collected after cooling. The separation of the two products was achieved by preparative tlc on silica-gel plates (40 x 20 x 0.2 cm) using CHCI 3 / MeOH 9: 1. The faster running band (R r 0.83) was extracted with CHCl 3 and gave after evaporation and recrystallization from EtOH 0.083 g As a reduced folate derivative, LV is tra nsported into cells via an energy-requiring and saturable carriermediated process. Moreover, its accumulation, as well as that of its subsequent biologically active metabolites such as 5,10-methylenetetrahydrofolate, is promoted by conversion to non-effluxing polyglutamates (12, 13) . However, because the polyglutamylation of LV is less efficient than that of other reduced folates (14) , its uptake may be limiting where expansion of the 5,1 O-methylenetetrahydrofolate pool and eventual potentIation of FU are concerned. Tumors lacking the ability to efficiently transport reduced folates may be expected to be less responsive to LV + FU than tumors with a normal capacity for reduced folate transport. This situation that could arise, for example, in a patient whose tumor after therapy with MTX has become refractory as a result of a transport mutation . Recent evidence suggests that impaired LV uptake may even arise collaterally with resistance to agents other than antifolates. Specifically, Osieka and coworkers (15) groups. This paper, which is. to our knowledge, the first detailed report on the chemical synthesis of LV diesters, describes the preparation of a representative number of these compounds in good yield by alkylation of the disodium or dicesium salt of LV with an alkyl or aralkyl halide in DMSO.
7-A zido-6-chloro-I ,3-dimethy llumazine
Treatment of the free acid of LV with two molar equivalents of l-iodohexane and four molar equivalents of sodium carbonate in DMSO at room temperature afforded a relatively non-polar product which, unlike LV itself, could be passed readily through a silica gel column using various chloroformmethanol mixtures. Diester 2 was obtained in 54% yield, a value comparable to that found earlier in the reaction of l-iodohexane with MTX in the presence of cesium rather than sodium carbonate (3). In the hope that the carboxylate groups would be more efficiently alkylated if the counter-ion were cesium instead of sodium, the free acid of LV was converted to a dicesium salt by dissolving it in water, adjusting the pH to 7.5 with 20% cesium carbonate, freezedrying thc solution, and removing final traces of moisture by azeotropic distillation with benzene. Suspensions of the thoroughly dried dicesium salt in dry DMSO were then treated with 4 molar equivalents (twofold excess) of benzyl or 3,4-dimethylbenzyl chloride for 42 h to obtain the diesters 3 and 4, respectively. In a variant of this method, a mixed suspension of LV free acid and cesium carbonate in DMSO was treated with 2,4,6-trimethylbenzyl chloride for 22 h or 4-methoxybenzyl chloride for 22 h to obtain the diesters 5 and 6, respectively. Non-optimized yield were mostly 60-70%, and it appeared to make little difference whether the reaction was performed with the dicesium salt of LV or with the diacid in the presence of sodium or cesium carbonate.
Nmr spectra were obtained for two of the diesters (2 and 3) in d 6 -DMSO solution. Although it was not possible to resolve the peaks corresponding to the OCH 2 protons of the r:t-and ,),-ester groups in 2, discrete singlets at 84.97 and 8 5.02 were readily discernible in the spectrum of the dibenzyl ester 3. The upfield signal was assigned to the r:t-ester, whereas the downfield signal was assigned to the ,),-ester. Interestingly, the resonance signal corresponding to the N 5 -formyl group was split into two peaks of roughly equal area, totaling one proton, at 88.2 and 88.3 (NCH = 0). These results are consistent with hindered rotation of the amide bond.
Since it had been previously observed that 2,6-dichlorobenzyl bromide reacts faster than other benzylic halides with the carboxyl groups in MTX (3), it was of interest to extend this observation to LV and folic acid. Treatment of LV in DMSO with two molar equivalents of2,6-dichlorobenzyl bromide (i. e., a stoichiometric amount rather than an excess) afforded a 67% yield of diester 7 after only 4 h. The high reactivity of 2,6-dichlorobenzyl bromide is believed to be due to the electron-withdrawing character of the two ortho-chloro substitutents and to the steric relief afforded by replacement of the bromine with a smaller oxygen atom when an ester is formed.
Esterification of the experimental antitumor agent (6RS)-5-methyl-5,6,7,8-tetrahydrohomofolic acid (8) (reviewed in ref. 17 ) was also examined, with the aim of assessing the effect of N 5 -methyl versus N S-formyl substitution. Reaction of 8 with a stoichiometric amount of benzyl chloride and a twofold molar excess of cesium carbonate in DMSO was found to be slow, and was clearly not complete after the normal 24--48 h. After 88 h, however, a crude product was obtained whose TLC showed mainly one spot with Rr 0.86. Purification by column chromatography and preparative TLC afforded a low yield (10%) of a compound whose microanalysis indicated the empirical formula C42H4SN 70 6 . 0.25H 2 0 and was therefore consistent with the incorporation of three benzyl groups. The nmr spectrum of this compound, in CDC!; solution, showed it to be a diester since the CH 2 protons of the (J..-and y-benzyl ester groups were visible at 8 5.0 and 8 5.1, respectively. In addition there were two aromatic singlets, one at 87.30 (ten protons) which we assigned to the ester O-benzyls, and the other at 8 7.17 (five protons) which we viewed as being consistent with an N-benzyl group. This compound was therefore provisionally formulated as the N 3 -benzyl derivative. It appears from these results that the NS-formyl group in 1 may indirectly decrease the nucleophilic reactivity of N 3 , thereby diminishing susceptibility to attack by alkyl or aralkyl halides. In an effort to minimize N 3 -benzylation, 8 was allowed to react with henzyl chloride and half the normal amount of cesium carbonate. After 4 days, TLC revealed mainly two spots with Rr 0.72 and Rr 0.86. The slower-moving spot, which we assumed might be the diester 10 because its R r was similar to those of the LV diesters, was isolated , albeit in relatively low yield (19%), by preparative chromatography. Its stucture was confirmed as 10 by elemental analysis, which indicated the empirical formula C3sH 3XN 70 6 . 2H 2 0, and on the basis of the nmr spectrum , which was similar to that of 9 except for the absence of a signal at 87.17.
Further support for the idea that the N 5 -formyl group in LV may indirectly enhance the selectivity of alkylation of the glutamate carboxyls by diminishing alkylation of the pteridine moiety was derived from the 145 reaction of benzyl chloride with the cesium salt of folic acid in DMSO. TLC analysis of the crude product obtained after 41 h at room temperature revealed mainly two relatively fast-moving spots with Rr 0.84 (Product A) and Rr 0.87 (Product B). The two products were separated by column chromatography and analyzed. Product A (35% yield, mp 105 -114 "C) was found to have the empirical formula C4oH 37N 70 6 . 2H 2 0, and product B (15% yield, mp 197 -202 "c) was found to have the empirical formula C 4o H )7N 7 0 6 . 0.5H 2 0. Thus both products were tribenzyl derivatives, and no dibenzyl folate was obtained. It is of interest in this regard that Temple and coworkers (18) have reported that alkylation of folic acid with methyl iodide in N,N-dimethylacetamide in the presence of potassium carbonate fails to stop at the dimethyl ester stage, but gives instead N' ,N 3 -dimethylfolate. It was also found that reaction of dimethyl folate with methyl iodide in the presence of base yields dimethyl N 3 -methylfolate. On the basis of this precedent which suggests that N 3 is favored over N' (as well as N'O) for alkylation, we believe that product B from the reaction of benzyl chloride with folic acid was probably dibenzyl N 3 -benzylfolate. Product A may have been the N'-benzyl diester, though other sites of alkylation, such as the 2-amino group, N lo , or 0 6 , were not ruled out. Because our primary interest was in the esterification of LV and not folic acid, further work on these compounds was not pursued. Intcrestingly, when the esterification of folic acid was performed with 2,6-dichlorobenzyl bromide the 2,6-dichlorobenzyl ester 11 was obtained. The yield of 11 was comparable to that of the LV esters, and concomitant alkylation of the pteridine moiety, unlike the reaction of folic acid with benzyl chloride, did not appear to be a problem.
In summary, this report describes a mild and general method of neutral esterification of LV using alkyl or aralkyl halides in the polar solvent DMSO. An easy opportunity is thereby afforded to obtain lipophilic diester derivatives for evaluation of their biochemical and pharmacologic properties in comparison with the parent acid. Preparation of leucovorin freee acid (1) from the calcium salt Calcium leucovorin (1 g) was dissolved in H 2 0 (20 mL) with slight warming, and the solution was treated dropwise with formic acid (0.5 mL) until the pH reached 3.5, cooled to 3 D C in an ice bath, and filtered. The filter cake was dried in vacuo over P 2 0 S to obtain a beige solid (681 mg). On overnight storage in the refrigerator, the mother liquor yielded 1 as a paleyellow solid (56 mg) which was chromatographically identical to the first crop; total yield 737 mg (67%); mp 249 -252 cC; TLC: Rr 0.66 (Eastman 13254 cellulose, 1 : 1 EtOH, pH 7.4 phosphate buffer). This material was used without further purification to prepare the diesters.
Experimental
Leucovorin di-n-hexyl ester (2) 1-lodohexane (85 mg, 0.4 mmol) was added to a suspension of leucovorin free acid (105 mg, 0.2 mmol) and Na2CO] (42 mg, 0.4 mmol) in DMSO (4 mL), and the mixture was stirred at room temperature for 24 h. After evaporation of the DMSO, the residue was triturated with H 2 0 (25 mL), filtered, and dried in vacuo over P 2 0 S to obtain a cream-colored solid (105 mg). The solid was dissolved in a minimum of 98: 2 CHClrMeOH and applied onto a silica gel column (5 g) which was eluted successively with CHClrMeOH mixtures (98: 2, 25 x 8 mL; 96 : 4, 25 x 8 mL; 94: 6, 25 x 8 mL; 92 : 8, 25 x 8 mL). The column eluates were monitored by TLC (silica gel, 3: 1 CHCb-MeOH) and tubes 39 -72 were pooled and evaporated to obtain a pale-yellow solid ( 
Leucovorin dibenzyl ester (3)
Leucovorin free acid (200 mg, 0.38 mmol) was suspended in H 2 0 (4 mL), the pH of this mixture was adjusted to 7.5 with 20% CS 2 C0 3 (1 mL), and the solution was evaporated to dryness. The residue was dried azeotropically with benzene (2 x 20 mL) and then suspended in DMSO (6 mL) and treated with a solution of benzyl chloride (192 mg, 1.52 mmol) in DMSO (1.5 mL) . After being stirred at room temperature for 42 h, the mixture was evaporated to dryness, and the residue was triturated with H 2 0 (5 mL) and filtered. The crude diester was washed with H 2 0 and dried overnight in a vacuum desiccator over P 2 0 S to obtain a beige solid (271 mg). A portion (150 mg) of this material was chromatographed on a column of silica gel (8 g) which was eluted successively with CHClrMeOH mixtures (100 mL each) ranging in composition from 99: 1 to 91 : 9. The MeOH content of the eluents was increased in 1 % increments, and individual fractions (9 mL) were monitored by TLC. Tubes 51 -100 were combined and evaporated, and the residue was triturated with ether and dried in vacuo over P 2 0 S to obtain a beige solid (95 mg); the rest of the crude diester (120 mg) was purified similarly. The total yield of 3 was 173 mg (70%); mp 133 -138°C. TLC: Rr 0.69; JR: v 1750 (ester C = 0); UV: Amax 293 nm (E 35,580). Two repetitions of this synthesis, one starting from 0.5 g of leucovorin free acid and the other from 0.9 g, gave yields of 57 and 78%, respectively. Leucovorin di- ( 3,4-dimethylbenzyl) ester (4) Leucovorin (100 mg, 0.19 mmol) was converted to its dicesium salt and the latter allowed to react with 3,4-dimethylbenzyl chloride (118 mg, 0.76 mmol) in DMSO as described for the dibenzyl ester. The crude product (160 mg) was chromatographed on a column of silica gel (7 g ) by elution with CHClrMeOH mixtures (98 : 2, 44 x 9 mL; 96 : 4, 44 x 9 m L; 94 : 6, 44 x 9 mL). Tubes 61-110 were pooled and evaporated to a pale-yellow solid (40 mg, 30 % yield). Analytically pure 4 was obtained after a second passage through silica gel; mp 136 -143 "C; TLC : Rr 0.81. Leucovorin di- (2, 4,6-trimethylbenzyl ) ester (5) 2,4,6-Trimethylbenzyl chloride (138 mg, 0.8 mmol) was added to a suspension of leucovorin free acid (105 mg, 0.2 mmol) and Cs 2 CO J (130 mg, 0.4 mmol) in DMSO (5 mL), and the mixture was stirred at room temperature for 22 h and worked up as in the preparation of the di-n-hexyl ester. The crude diester was chromatographed on a column of silica gel (6 g) which was eluted with CHClrMeOH mixtures (98 : 2. 43 x 7 mL; 96: 4, 43 x 7 mL). Tubes 56 -82 were combined and evaporated under reduced pressure to obtain 5 as a pale-yellow solid (88 mg, 60% yield); mp 147 - 
Anal

Leucovorin di-( 4-methoxybenzyl) ester (6)
A solution of 4-methoxybenzyl chloride (125 mg, 0.8 mmo!) in DMSO (1 mL) was added to a suspension of leucovorin free acid (105 mg, 0.2 mmol) and CS 2 C0 3 (130 mg, 0.4 mmol) in DMSO (4 mL). After 42 h at room temperature, the DMSO was evaporated under reduced pressure and the resid ue triturated with H 2 0 (30 mL) . The resulting gum was extracted with CHCh (5 x 20 mL) and the combined CHCl J extracts were washed with H 2 0 (30 mL), dried over Na2S04, and evaporated. The brown-colored semi-solid residue was chromatographed on a column of silica gel Esterification of ( 6RS) -5-methyl-5,6,7,8- tetrahydrohom()j"olic acid (8) with benzyl chloride Procedure A A solution of benzyl chloride (50.6 mg, 0.4 mmol) in DMSO (1 mL) was added dropwise to a stirred suspension of 8 (94.7 mg, 0.2 mmol) and CS 2 C0 3 (130 mg, 0.4 mmol) in DMSO (3 mL). After being stirred at room temperature for 88 h, the reaction mixture was evaporated under reduced pressure, and the residue was triturated with pH 7.4 phosphate buffer, washed with H 2 0 , and dried in vacuo over P 2 0 S to obtain a beige solid (104 mg). The product was applied onto a silica gel column which was eluted with CHClrMeOH mixtures (99: 1, 22 x 9 mL; 98: 2, 22 x 9 mL). 
Esterification of folic acid with benzyl chloride
Folic acid (100 mg, 0.23 mmol) was dissolved in H 2 0 (2 mL) by addition of 20% CS 2 C0 3 (0.5 mL) to bring the pH to 7.5. The solution was evaporated to dryness under reduced pressure and the residue was dried azeotropically with benzene (2 x 15 mL) and then in vacuo over P20S' The dried cesium salt was suspended in DMSO (4 mL) and a solution of benzyl chloride (86 mg, 0.68 mmol) in DMSO (1 mL) was added. After 41 h at room temperature, the DMSO was evaporated under reduced pressure, and the residue was triturated with H 2 0 (25 mL), filtered, washed with H 2 0, and dried in vacuo over P 2 0 S to obtain a yellow-
Rosowsky and Yu : Leucovorin esters orange solid (53 mg) whose TLC showed two main spots with Rr 0.84 (product A) and Rr 0.87 (product B). The darkest spot was that of product B. The crude product mixture was dissolved in a minimum volume of 98: 2 CHClr MeOH and applied onto a silica gel column (7 g ) which was eluted with CHClrMcOH mixtures (98 : 2, 22 x 9 mL; 96: 4, 22 x 9 mL; 94: 6, 22 x 9 mL). Individual tubes were monitored by TLC, and appropriate tubes were combined and evaporated. Tubes While it appeared from the microchemical analyses that compounds A and B were isomeric tribenzyl derivatives, the position of benzylation on the pterin moiety was left unassigned.
Folic acid di-( 2,6-dichlorobenzyl) ester (ll)
A solution of 2,6-dichlorobenzyl bromide (220 mg, 0.92 mmol) in DMSO (3 mL) was added at a rate of 1 mLjh to a stirred suspension of folic acid (200 mg, 0.46 mmol) and Na2CO) (0.92 mmol) in DMSO (5 mL), and after 2 days at room temperature the reaction mixture was evaporated to dryness under reduced pressure. The residue was triturated with H 2 0 (30 mL), and dried in vacuo over P 2 0 S . This material (340 mg) was then triturated with 3: 1 CHCh-MeOH and the insoluble residue collected as a yellow solid by centrifugation (135 mg). The supernatant was evaporated and the residue chromatographed on a silica gel column (20 g) by elution with CHClrMeOH mixtures (95:5,33 x 9 mL; 9 : 1, 22 x 9 mL; 4 : 1, 22 x 9 mL; 7:3, 110 x 9 mL). Tubes 64 -144 were pooled and evaporated to obtain a yellow solid (34 mg). This material was indistinguishable from the main product; total yield 174 mg 2) . In vivo , it has been suggested that PH2 may accumulate as a result of dihydropteridine reductase (DHPR) (EC. 1.6.99.7) inhibition or deficiency (3), or following oxidative catabolism of tetrahydrofolates (4). PH2, in vitro, is reported to be an inhibitor of tyrosine hydroxylase (EC . 1.14.16.2) (5), indicating that impaired aromatic amino acid hydroxylation may occur in situations leading to an intracellular accumulation of PH2 .
In order to study the effects of PH2 on cellular systems it is necessary to have stable solutions of this compound. Aqueous solutions of PH2, however, undergo hydration to 6-hydroxy-5,6,7,8-tetrahydropterin (60H-PH4) (6) . At neutral pH, addition to the 5,6 double bond is not favoured and requires a strong nucleophile (6) . Consequently the equilibrium between PH2 and 60H-PH4lies predominantly towards PH2 with very little 60H-PH4 being initially present (6) . However, the rapid autoxidation of 60H-PH4 to 7,8-dihydroxanthopterin (XH2) disrupts this equilibrium, resulting in further PH2 hydration (6) (Fig. 1) . The instability of PH2 with the formation of XH2 makes enzyme inhibitor studies difficult and suggests the possibility that the reported increased excretion of XH2 in DHPR deficiency (7) may arise from PH2 hydration and subsequent oxidation.
In this paper we demonstrate that prevention of the oxidation of 60H-PH4 allows preparation of relatively pure PH2 solutions which are stable at 37°C, pH 6.8, for prolonged periods of time.
Material and Methods
5,6,7,8-tetrahydropterin
(PH4) dihydrochloride, XH2, xanthopterin (X) and pterin (P) were purchased from Dr. B. Schircks Laboraturies (Jona, Switzerland). 2,6-Dichlorophenolindolphenol (DCIP) a nd potassium ferricyanide were obtained from Sigma C hemical Co. (Poole, E ngland). Dithioerythritol (DTE) was purchased from Aldrich Chemical Co. (Poole, England). All other chemicals and reagents were Analar grade.
PH2 was prepared in 0.1 M phosphate buffer, pH 6.8, by the oxidation of PH4 to quinonoid dihydropterin (qPH2) using either a 2: 1 molar ratio of potassium ferricyanide: PH4 (8) or an excess of DCIP (2). The excess DCIP was immediately removed by extraction with ether. Rearrangement of qPH2 to PH2 was monitored by UV spectroscopy at 227 nm at room temperature (2) and was seen to go to completion. A portion of the 7,8-dihydropterins formed by DCIP oxidation was further oxidized by acid iodine treatment as described by Fukushima and Nixon (9) . UV spectra were obtained using a Perkin-Elmer Lambda 5 dual beam UV / Visible recording spectrophotometer. Reversed-phase HPLC analysis, u sing fluorescence/electrochemica l detection, of dihydro and fully oxidised pterins was performed as described by Howells et al. (10) .
Results and Discussion
Oxidation of PH4 (800 J.lM) with either ferricya nide or DCIP and subsequent rearrangement of qPH2 produced a solution with a maximum absorbance at 227 nm after 30 minutes. Although the UV spectrum of this product was characteristic of PH2 (2, 6), with three broad peaks centred at 227 nm (Emax 26120 mol/L cm-I ) 276 nm (Em ax 10850 mol/ L cm -I ) and 324 nm (Emax 5400 mol/ L cm -1), immediate HPLC a nalysis revealed the presence of XH2 and P (identified by co-chromatography with commercially availa ble standards), in a ddition to the implied PH2 peak (Fig. 2) culated by its absorbance at 324 nm (Em ax 5400 mol/L cm -I) following subtraction of the contributions from XH2 and P. The concentrations of these were determined by HPLC and the absorbance at 324 nm calculated (Emax 1911 mol /L cm -I for XH2, and 2683 mol/L cm -1 for P) . The relative proportions (%)"
of PH2, XH2 a nd P (n = 5 ± SD) were 84.6 ± 6. t 8, 7.8 ± 4.1 and 7.8 ± 3.7 respectively. The mean conversion of PH4 to these pterins was 106 ± 13% , demonstrating that other undetected pterins, if present, were there in relatively small amounts. ; § 
+------------------------------------+ 100
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Time ( Solutions of PH2, prepared by either ferricyanide or DCIP oxidation of PH4 and subsequent qPH2 rearrangement, were not stable. The formation of XH2 from PH2 was monitored by HPLC. The concentration ofPH2 fell rapidly, whilst the XH2 concentration increased (Fig. 3a) . This is attributed to 60H-PH4 autoxidation and increased PH2 hydration (Fig. 1 ).
Since DTE retards autoxidation of tetrahydropterins (6, 10), its effects on the stability of PH2 were examined (Fig. 3b) . In the presence of DTE there was no appreciable change in the PH2 and XH2 concentrations over a 35 minute period. The addition of DTE (2 mg/ml) to newly formed PH2 solutions allowed the preparation of a range (20 -1200 J..lM) of relatively pure (80-94%), stable, PH2 solutions by serial dilution into buffer also containing DTE (2 mg/ml) .
It is possible that nucleophiles within the DTE/ buffer mixture could add to the 5,6-double bond of PH2.
To confirm the presence of PH2, samples of the putative PH2 solution were oxidised (9) . HPLC analysis of the products of the oxidation demonstrated the disappearance of the suggested PH2 peak and an increase in the pterin component (not shown). The mean percentage conversion of the implied PH2 into pterin was 86% (3 observations, range 81 -91 %). These findings demonstrate the intact nature of the 5,6-double bond and show that PH2 was the predominant species in the original solutions.
Oxidation of PH4 followed by a period of time for qPH2 rearrangement and subsequent DTE addition provides a simple method for the production of stable solutions of PH2, suitable for incorporation into enzyme assay systems.
Pteridines
Introduction
The methods commonly used for measuring folates in biological material a re microbiological (1) or radioisotope dilution assays (2) . The identification of individual folates is carried out using differential microbiological assays with L. casei, P. cerevisiae and S.faecalis (3). This process is time consuming, requiring the maintenance of three stock cultures in appropriate culture media . High performance liquid chromatography (HPLC) using electrochemica l detection has been proposed as an alternative, however this is not yet a routine procedure (4). Bioautography, a method which combines chromatography and microbiological growth response, is sensitive, specific but qualitative (5).
Folates can be differentially oxidised (6), giving products some of which may be microbiologically active and others which are inactive. This may be utilised to differentiate between individual folates.
Materials and Methods
Folic acid was obtained from Sigma. 10-Formylfolic acid (10-CHOFA) was prepared by the method of 1) Author to whom correspondence should be a ddressed. Blakley (7). 5-Methyltetrahydrofolic acid (5-CH3THF) was obtained from Eprova, Switzerland. 5-Formyltetrahydrofolic acid (5-CHOTHF) was a gift from Lederle. 10-Formyltetrahydrofolic acid (10-CHOTHF) was prepared by acidifying 5-CHOTHF, leaving for one hour at 25 "C in the dark then returning to neutral pH . Tetrahydrofolic acid (THF) was obtained from Eprova. The iodine solution was prepared by saturating a 2 gi l potassium iodide solution with crystalline iodine.
The Lactobacillus casei folate assay was carried out by a semi-automated method (8).
For iodine oxidation , 2.5 ml of 10 Jlg /ml solutions of folates were placed in 5 ml volumetric flasks. For acid and alkaline oxidation, 0.25 ml of 2M HCI a nd 2M NaOH respectively were added followed by 0.1 ml of iodine solution which was sufficient to provide an excess leaving the solution yellow. After one hour at 25 DC 0.05 g of ascorbic acid was added which made the solution colourless. The solutions were returned to pH 7.0 with M NaOH and M HCl and the volumes were made to 5.0 ml with 0.2M phosphate buffer pH 6.1. At pH 7.0 the oxidation was repeated with the addition of 0.1 ml of 5 gi l catalase immediately before the iodine. The experiments were repeated using manganese dioxide to replace the iodine solution, 0.1 g of manganese dioxide was added in the powdered form. After addition of 0.05 g ascorbic acid the material was centrifuged at 2000 g for three minutes. THF was oxidised by iodine at acid and neutral pH and the pterin formed was quantitatively measured by HPLC (9) .
Results
The findings of the microbiological assays are given in Table 1 . With iodine at neutral pH the activities of folic acid and 5-CHOTHF were consistently reduced to 5% and 30% respectively. 5-CH3THF had an intermediate activity at 50-70% whilst 10-CHOTHF and 10-CHOFA showed almost 100% activity.
Under acid conditions 5-CH3THF retained less than 10% of its original activity whereas the other folates were unaffected. At alkaline pH, 10-CHOFA again proved to be completely stable. Folic acid and 5-CH3THF had 50% residual activity. 10-CHOTHF and 5-CHOTHF fell to 10% and THF gave 100% pterin at acid and neutral pH.
Treatment with catalase afforded some protection against oxidation at pH 7.0. 5-CH3THF increased from 70% to 100% activity.
Iodine and manganese dioxide gave similar results at all three pH levels, therefore only the figures for iodine are quoted.
Discussion
Tetrahydrofolic acid (THF), The ability to identify folate analogues following iodine oxidation at acid, alkaline and neutral pH using Lactobacillus casei is confirmed and is potentially of clinical use. By varying pH , selective inactivation occurs leaving other analogues unaffected and therefore available for Lactobacillus casei in the assay. Subsequent treatment with conjugase would further enable the identification of polyglutamates.
All five folates used in this study gave responses which could be used to identify them. Folic acid and 5-CH3THF show no activity after neutral and acid oxidation respectively. 10-CHOFA can be identified because its activity remains unchanged under all the conditions tried . To separate 5-CHOTHF a nd 10-CHOTHF is more difficult as they show similar responses. However, with neutral oxidation and the addition of catalase, 5-CHOTHF has 30% activity whilst 10-CHOTHF does not lose any activity. THF is rapidly and totally oxidised to pterin at pH 7.0 by iodine in potassium iodide. 
Introduction
Proteins that bind folylpolyglutamates tightly occur in relatively high concentrations in the cell. It is expected that these proteins can limit the rate of flux of i-carbon units through various folate-requiring reactions by sequestering the folate coenzyme. The role of these proteins in limiting the amount of free coenzyme will be discussed . The tightly bound folylpolyglutamates may also control the catalytic function s of the "folate binding proteins" as well, and this role will also be discussed. Folylmonoglutamates, rather than the polyglutamates, are associated with certain 
The Major Folate Binding Proteins
About half of the folates in the cytoplasm of liver (5) are bound tightly to three proteins, namely, 10-formyl-H 4 PteGlu dehydrogenase (6) , glycine N-methyltransferase (7), and dihydrofolate reductase (8, 9) . A stable elevation (25 -35 fold) in dihydrofolate reductase can occur with the onset of methotrexate resistance in cultured cells (10, 11) . Although it is possible that this increase can result in a higher proportion of cellular folylpolyglutamates that are protein-bound, a severe depletion in the free folates is an unlikely consequence, as the cells continue to grow, though at a rate slower than that of the drug-sensitive cells.
The two major "folate binding proteins" are glycine N-methyltransferase and 10-formyl-H 4 PteGlu dehydrogenase, where the methyltransferase binds nearly twice as much of the coenzyme as the dehydrogenase (12) . The concentration of the dehydrogenase subunits in the cell, however, may be greater (4 -12 fold) (13, 14) than those of the methyltransferase (15, 16) ( Table 1 ). There is some thought that glycine Nmethyltransferase binds only one molecule of 5-methyl-H 4 folate per tetramer (17) .
Glycine N-methyltransferase is part of the cell enzymatic machinery for limiting the toxic effects of excess methionine. The methyl groups from the excess amino acid can be funneled off by conversion to Sadenosylmethionine (Ado Met) followed by the transfer to glycine, yielding monomethylglycine (sarcosine) in a reaction catalyzed by the above enzyme (18 (12) . The enzyme is low in fetal tissues (21) . Rabbit liver contains unusually high levels of the methyl transferase, as determined by enzyme activity assays (21), as well as high levels of serine hydroxymethyltransferase ( Table 1 ), suggesting that an unusually high proportion of folates in this tissue is associated with protein.
Metabolic studies demonstrating the prompt and near total contraction of the pool of 5-methyl-H 4 folate with a methionine injection (22) and the prompt accumulation of sarcosine following a methionine injection (18) seem not to be consistent with the prolonged and tight association of folate with glycine N-methyltransferase revealed by chromatographic studies.
10-F ormyl-H 4 PteGIu dehydrogenase clearly functions
in amino acid metabolism, as shown by the substantial release of 14C-C02 following injections of r 4 C]histidine (22) . However, it is puzzling that an enzyme that is used to catabolize what seem to be valuable 1-carbon units should occur in relatively high concentrations in the cell ( Table 1) . The protein may serve as a "tetrahydrofolate buffer," by binding H 4 folates when their concentration in the cell rises too high. The enzyme is inhibited by tetrahydrofolates, where the K; is under 0.3 f.!M, a concentration clearly within the physiological range (13) . The inhibition by H 4 folates would have an effect complementary to that of the "tetrahydrofolate buffer" function, namely, to increase the ratio of free 10-formyl-H 4 folatejH 4 folate.
Nitrous oxide treatment provokes a contraction of the H 4 folate pool. The concentration of H 4 folate decreased from an inital 52% of the total folate pool down to 38% in one experiment (Brody & Stokstad, in press). One might expect this decrease to result in the release of 10-formyl-H 4 PteGlu dehydrogenase from inhibition, with a consequent depletion of tissue 10-formyl-H 4 folates. This scenario seems not to be supported by data showing that the proportion of liver folates occurring as 10-formyl-H 4 folate was maintained at about 20% with 4.5 h nitrous oxide treatment (Brody & Stokstad, in press). The concentration of enzyme subunits was calculated by dividing the total mg protein in the crude homogenate by the foldincrease in specific activity with purification to homogeneity, a nd dividing by the molecular weight of the subunit. The concentration was expressed on a subunit basis for the sake of uniformity and because the molecula r weights of some of the native enzymes are ambiguous.
') These values (13, 15) are underestimated as they were calculated from the total ~mol of protein recovered without correcting for the percent yield. The yield is difficult to estimate as some activation of the enzymes occurred during purification due to the loss of endogenous inhibitors, i. e., H 4 folate and 5-methyl-H 4 folate. The corrected values, which may either be under or overestimations of the true values, are listed in brackets.
2) The value for glycine N-methyltransferase (16) is underestimated as it was calculated from the nmol of [3H]folate remaining bound after chromatographic purification and was not corrected for the unknown loss of [3H]folate or loss of protein itself occurring during the purification procedure.
3) Thymidylate synthase can bind two molecules of fo la te in the presence of FdUMP (73) though it is not clea r how many physiologically relevant folate binding sites are present on the dimer. 4) The value was calculated assuming that 70% of the liver weight is intracellular water. The concentration of glycine required to provoke the tight binding of folylpolyglutamates to serine hydroxymethyltransferase is 0.1 m M , well below the actual concentration of free glycine in rat liver (5 mM) (24) . The concentration of plasma glycine in the human (25, 26) , dog (27) , and rat (24, 28) , is about 0.2 mM, while that in the pig is higher (1.0 mM) (29) . This suggests that the concentration of glycine in pig liver is at least 1.0 mM.
There is some indication that folates bind to methionine synthetase during its purification (30) . However, because of the low concentration of this enzyme in the cell (Table 1) , there is no reason to suspect that this binding limits the availability of the coenzyme for other reactions.
GAR and AICAR transformylases occur in high concentrations in avian cells ( Table 1) . Folates bind only moderately tightly to these enzymes. The Kill ' S of rolates as well as the Kj of the inhibitor H 2PteGlus for these enzymes are in the 1 -5 ~M range (31 -34) . Dihydrofolate, which expands in concentration with methotrexate treatment (35 -37) , inhibits the activity of AICAR transformylase. The high concentration of this enzyme, at least in avian liver, would tend to minimize the inhibitory effects of the H 2 folate.
Effects on the Activities of Thymidylate Synthase and Methylene Tetrahydrofolate Reductase
Thymidylate synthase may be located in both the cytosol (38) and nucleus (39, 40) . The activity of this enzyme increases in cultured cells (41) and in fetal (42) and regenerating (43) The activity of thymidylate synthase may be influenced by folate binding proteins. An inhibition of serine hydroxymethyltransferase by 5-methyl-H 4 folate may limit the activity of thymidylate synthase by restricting the generation of 5,10-methylene-H 4 folate. The binding of H 4 folate by 10-formyl-H 4 PteGlu dehydrogenase may also limit the activity of thymidylate synthase by decreasing the concentration of H 4 folate available to serine hydroxymethyltransferase.
5,10-Methylene-H 4 PteGlu reductase utilizes 5,10-methylene-H 4 folate as a substrate, as does thymidylate synthase. The Michaelis-Menten constant for the folate substrate for the reductase of pig liver (48) is ten-fold lower than for thymidylate synthase of pig li ver (49) , as well as of other sources (44) . Hence, 5.10-methylene-H 4 PteGlu reductase is unlikely to be as sensitive as thymidylate synthase to changes in the availability of the folate substrate. As noted above, the rate of nux of 1-carbon units via methylene reductase and thymidylate synthase was compared in one study. The concentration of methylene reductase in the cell is low, as is the case for thymidylate synthase. Thus, the tight binding of folates by the reductase (Km = 0.26 and 0.1 ~M for 5,1 O-methylenc-H 4 PteGIus a n d6 (48») would not be expected to influence the availability of folate s to other enzymes.
Methylene reductase tightly binds dihydrofolypolyglutamates. H 1 PteGlu5 inhibits the activity of the reductase with a K i 01'0.19-0.81 ~M (48) . concentrations that might be expected to arise during methotrexate treatment. A result of this inhibition, should it be shown to occur in vivo. would be to spare the folate substrate for use by thymidylate synthase and, possibly to enhance the chemotherapeutic propertics of 5-fluorodeoxyuridylate.
The glycine cleavage system, dimethyl-and monomethylglycine (sarcosine) dehydrogenase. and a unique form of serine hydroxymethyltransferase, reside exclusively in the mitochondria. The concentrations of these proteins on a ~mol/kg tissue basis are relatively low (Table 1 ). The proportion of serine hydroxymethyltransferase activity associated with the mitochondria is not well established, as published figures range from 5% (23) to 40% (50) . This range of figures may have been generated artifactually from differences in sedimentation of the mitochondria with the nuclear fraction, as pointed out by Zamierowski and Wagner (5) . About one third of mitochondrial folates are tightly bound to dimethyl-and monomethylglycine dehydrogenase (5) . Although the bound folate is not required for the expression of enzyme activity (51) , the folate prevents the release of the potentially toxic product, formaldehyde (52) .
Conclusion
An examination of the concentrations of various enzymes in liver and of data, where available, concerning their tendency to bind folylpolyglutamates, revealed that serine hydroxymethyltransferase may be a major folate-binding protein in some animals. The data on concentrations and on binding excluded other enzymes from consideration as major "folate binding proteins ." As yet, little is known of the possible association of folates with the "folate binding proteins" in vivo or on the proposed regulatory effects of the bound folates . The potential importance of the folate binding proteins in regulating the amount of cofactor available for use by thymidylate synthase suggests that the behavior of the binding proteins in normal and cancer cells should be subjected to closer scrutiny. Neopterin, a pyrazino-(2,3-d)-pyrimidine derivative, originates from guanosine triphosphate (GTP) and is secreted by human macrophages which have been exposed to interferon-(IFN)-gamma (1) . Neopterin measurement provides a means to assess the activation state of the T cell/macrophage system (2) . In several malignant disorders, e. g., cancer of the uterine cervix (3), prostatic carcinoma (4), ovarian cancer (5) and lung cancer (6), neopterin concentrations have been proved to be of prognostic relevance: raised concentrations at the time of diagnosis were associated with an increased risk of death due to the disease.
Increased neopterin concentrations were reported from patients with haematological neoplasias (7 -9) . In this study we evaluated the predictive value of 
Patients and Methods
a ) Patients
In 1981, neopterin concentrations were measured in 115 patients with haematological neoplasias (7, 8) . Clinical follow-up was evaluable in 85 (74%) of these patients. Mean observation time was 68 months (range 4 -89). Clinical data were analyzed from 38 patients with HD, 36 with NHL, including 17 patients with chronic lymphocytic leukaemia (CLL), and from 11 patients with CML. Basic characteristics of patients are summarized in Table 1 . Similarly to HD, staging of NHL was generally made according to the ANN Arbor classification, with the exception of CLL, where the Rai classification was used (12) . For the assessment of the entire group, patients were divided into two categories: "early stage" was defined as stages 1/11 according to the Ann Arbor classification and stages 0/1/11 according to the Rai classification. Stages III/IV of both classifications were equally judged as "advanced stage".
In patients with NHL the mean value of urinary neopterin was significantly raised. Neopterin concentrations were higher than in HD patients. In contrast to the findings in HD there was a correlation between neopterin concentrations and the stage of the disease, advanced stage patients showing higher concentrations than patients with earlier stages. In CLL patients neopterin values were quite comparable to those in patients with other NHL entities.
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Chronic myelogenous leukaemia
The third group comprised 11 patients with CML. All of them were in chronic phase of the disease at the time when neopterin concentrations were measured. Patients with CML showed raised neopterin concentrations compared to healthy subjects. The mean value was within the same range as that in NHL, but significantly higher than in HD patients (Table 1) .
b) Neopterin measurement
Urinary neopterin was determined by an optimized and fully automated high pressure liquid chromatography technique (HPLC) without previous oxidative treatment as described elsewhere (13, 14) . By this reverse-phase technique, urinary creatinine is simultaneously determined in the same urine specimen. Neopterin concentrations are expressed as ~mol neopterin/mol creatinine.
c) Statistical procedures
The Kruskal-Wallis-test was used to assess a dependence of neopterin concentrations on tumour stage. Survival functions were constructed according to the product-limit method (15) , the dates of urine collection were used as starting point. The patients were dichotomized using the mean neopterin concentrations of each tumour group for further analysis.
Differences of survival functions between patients with low and high neopterin concentrations were tested by the generalized Wilcoxon test (16) . Multivariate analyses according to the Proportional Hazards model were performed in order to investigate the prognostic effect of one or more variables (17) . For the possible nonproportional effect of the type of disease on the base-line survival curves, a stratification procedure was employed (18) .
The role of raised neopterin as a risk factor independent from other variables was defined using a multivariate analysis. We used again the mean values as disease-specific "cut-off-Ievels". Values above these levels were judged as "high", those below as "low" levels. HD and NHL patients were analyzed together since in both groups patients with early stage and advanced stage could be evaluated. However, the type of the tumour was used as a stratification variable for the subsequent analysis.
Results
In Figure 1 A the overall survival of the three groups of patients (HD, NHL, CML) is graphically demonstrated. As expected, patients with HD show the best prognosis, more than 80% of patient being alive after 7 years. In NHL patients survival probability was about 60% after 7 years. CML patients had a median survival time of 4.5 years.
Hodgkin's disease
Within the observation time 6/38 patients (16%) died due to the disease. All of the six patients who died had advanced stage of disease and were treated at the time of neopterin measurement. Neopterin concentrations were significantly elevated in these patients compared with HD patients still being alive. This holds true even when only patients with advanced stage disease are compared. Survival probability was significantly lower in patients showing neopterin concentrations above the mean value (Fig. 1 B) .
Non-Hodgkin's lymphomas
Survival probability of NHL patients (Fig. 1A) was lower in patients with advanced stage disease (p < 0.0t). Patients with neopterin concentrations exceeding the mean value of NHL patients (547 !lmol / mol creatinine) had a significantly increased risk of death due to the disease (Fig. 1 C) . Similarly to the findings in HD patients, neopterin concentrations were of prognostic relevance in addition to the stage of disease. Out of the 36 patients with NHL 32 (89%) had NHL of low malignancy according to the Kiel classification, only 4/36 (11 %) suffered from NHL of high malignancy. Two of these 4 patients died from their disease, both had highly raised neopterin concentrations (1256 and 927 !lmol/mol creatinine, respectively).
Chronic myelogenous leukaemia
Again, survival was better in patients with lower urinary neopterin concentrations, the difference was, however, not significant (p > 0.05), probably intluenced by the lenght of the study. Markedly decreasing suryi\al was observed in the group of patients with 10\\ neopterin after an observation period longer than -+ years (Fig. 10) . The survival probability 2 years after neopterin measurement was significantly higher in patients with lower neopterin concentrations
A multivariate analysis of survival in patients with HD and NHL, stratified by the tumour type, revealed that high neopterin levels remained prognostically significant in addition to tumour stage. This is demonstrated by the regression coefficients shown in Table 2 . 
Discussion
The majority of patients suffering from haematological neoplasias shows raised concentrations of urinary neopterin (7, 9) . Mean values in our patients differed from one disease to another. Nevertheless, elevation exceeding the disease specific mean value represents a certain risk factor. The increased risk of death due to the disease defined by raised neopterin concentrations was established in all patients groups. It is independent of other known unfavourable signs, e. g. , advanced stage or presence of B symptoms.
Because of this prognostic relevance therapeutic consequences may be considered. Concerning HD, future clinical trials might take neopterin measurements into account, when a decision for either chemotherapy or radiotherapy or even combined therapy has to be made. This is of special interest in stage III patients. Additionally it could influence the duration of therapy. In NHL patients neopterin concentrations might heip to define groups of high risk, e. g., patients for whom a more aggressive treatment would be indicated to improve therapeutic results. To answer these questions, prospective studies are required. However, recent data by others confirm the prognostic relevance of urinary neopterin in NHL patients (9) . For CML the number of patients is too small to draw firm conclusions.
It remains to be shown if an increase of neopterin concentrations precedes the development of blast crisis or relapse after bone marrow transplantation , or if elevated neopterin correlates with other risk factors , e. g. , lack of Philadelphia chromosome or multiple cytogenetic abnormalities.
The fact, that in haematologic neoplasias, but also in various solid tumours, elevated neopterin -recognized as a sign for a stimulation of the cell mediated immune system -correlates with a worse prognosis, may seem surprising at first glance. A possible explanation for permanently elevated neopterin concentrations might be the presence of antigenic structures recognized by the immune system. Immunologic activation was further confirmed by the detection of increased concentrations of circulating IFN gamma in patients with haematological neoplasias (19 
5-met hyltetrahyd rofolate Betaine
Homocysteine agents leading to deficiencies of vitamin B12 and/or reduced folates , similarly as has already been documented in the case of nitrous oxide (5, 6).
Materials and Methods
Animals and preparation of enzyme extracts
Swiss female mice weighing 30 g approximately were sacrificed by cervical dislocation. Blood was collected for methemoglobin estimation. The kidneys and liver were removed, washed with cold buffered saline, then homogenized in 0.1 M phosphate buffer (pH 7.4) and centrifuged at 20,000 g for 20 min. The supernatant served as the source of the enzymes.
Enzyme assays
Vitamin Blrdependent methionine synthase (5-methyltetrahydrofolate: homocysteine methyl transferase, E. C. 2.1.1.13) was estimated according to Kamely et al. (7) , and betaine methyltransferase (betaine: homocysteine methyltransferase, E. C. 2.1.1.5) according to Skiba et al. (8) . The activity of methionine synthase estimated in the absence of exogenous vitamin BI2 was taken as a measure of holoenzyme content in the enzyme preparation, according to Mangum et al. (9) . Homocysteine was prepared from its thiolactone just before enzyme assay according to Duerre and Miller (10) . The standard reaction mixtures for estimations of both enzymes are given in the legend to Figures 1 and 2 . The reaction mixtures were incubated up to 1 h at 37°C in tightly closed Eppendorf tubes and the reaction was terminated by addition of 300 III ice-cold water.
[14C] Methionine formed in the reactions catalyzed by methionine synthase and betaine methyltransferase was separated from radioactive substrates on Dowex 1 x 8, 200-400 mesh , Cl-form (7), and OH-form (8), respectively. The radioactivity in effluents was measured in LS 3801 Beckman scintilation counter using scintillation coctails for aqueous solutions.
Butyl or isoamyl nitrite aqueous solutions were prepared and added to the reaction mixtures just before the onset of incubation. pH of the reaction mixtures was carefully checked.
Protein was determined by the method of Lowry et al. (11) and methemoglobin according to Evelyn and Malloy (12) .
Chemicals
Chemicals purchased from commercial sources were of analytical grade. found with 7.3 x 10 4 M mtnte in the incubation mixture and almost complete inhibition with 4.4 mM. It was also found that nitrites at concentrations causing considerable inhibition of methionine synthase activity had no effect on the activity of the second enzyme active in methionine synthesis, namely betaine methyltransferase (Fig. 2) . It points to specific inhibition of methionine synthase by nitrites and seems to exclude the possibility of their unspecific interaction with the enzyme protein.
The content of methionine synthase holoenzyme in the native mouse kidney preparation estimated by measuring enzyme activity in the absence of exogenous vitamin BIZ varied from 12 to 49%. To check whether nitrites exerted their inhibitory effect on methionine synthase through the action on vitamin B t2 , their influence on preparations with different holoenzyme content was compared. Results of the representative experiment are shown in Table 1 . The 7.47 x 10-4 M isoamyl nitrite which practically had no effect on the activity of methionine synthase estimated in the presence of added vitamin Bt l (100% holoenzyme), inhibited the activity of the native holoenzyme by about 40%. This compound at 3.73 x 10-4 M evoked nearly complete (90%) inhibition of methionine synthase in the absence of exogenous vitamin B 12 , while in its presence the degree of inhibition was much lower (33%). It seems therefore, that alkyl nitrites caused destruCl i"n 01 !'1;; :,m,l~l J.ni ('lunts o f endogenous vitamin B: r r;:'~e:1t I r . the ;Ull h' preparation of methionine syn thase .inc in ( On5equen(e a more pronounced denedse I,.f enzyme acti\'ity took place . Thus, the inhibitory effect of alkyl nitrites seems to be, at least in part. due to the destruction of\'itamin Butyl and isoamyl nitrite proved to be highly toxic to mice kept in an atmosphere saturated with these agents. Under these conditions the animals died in 1 -3 min, probably due to methemoglobin formation. An elevated level of methemoglobin was detected in the blood of animals receiving even small doses of nitrites administered as s. c. injections ( when compared with that in control mice. The number of mice is given in parenthcses. \Iice treated as described in the legend to Tabl e 2 were sacrificed .It the time indica ted.
The range o f the enzyme specific activity in the kidney and ii\cr of control mice was 5.34 -8.8 1 and 1.32 -3.20 nmoles/ h/ mg protein, respectively, similarly as in the untreated animals. The number of mice is given in parentheses.
the mice no significant change in the activity of methionine synthase in the liver and kidney of experimental animals was found ( Table 3) .
Discussion
In recent years the possible connection between longterm use of alkyl nitrites and Kaposi's sarcoma as well as opportunistic infections outbreak has been suggested (1) . The concern about volatile alkyl nitrites has also been related to their ability to nitrosate various amines or amides, as well as to other acute or subacute toxicities, among them methemoglobinemia (13) . Hersh et at. (2) in in vitro studies showed the high cytotoxicity of 1 % (i. e. 88.4 mM) isobutyl nitrite to human peripheral blood leukocytes. At lower nitrite concentrations the viability of leukocytes was preserved , but inhibition of incorporation of ra-diolabelled precursors into the respective macromolecules was observed.
Tn the present study we focused our attention on another aspect of alkyl nitrites action, namely on the metabolic consequences of oxidative destruction of vitamin B12 and 5-methyltetrahydrofolate. We found that butyl and isoamyl nitrites were in vitro effective inhibitors of methionine synthase at even much lower concentrations than that (0.18 M) shown by N M R spectroscopy (4) to cause decomposition of vitamin Btl and 5-methyltetrahydrofolate. In our studies almost complete enzyme inhibition was observed already at 4.4 -8.0 mM nitrite, while not only 0.18 M but even 44.2 mM nitrite denatured enzyme protein.
Differential susceptibility towards the nitrite action of the enzyme preparations characterized by various content of methionine synthase holoenzyme allows us to postulate that the inhibition of methionine synthase by nitrites is the result of the destruction of vitamin B t 2 , although the decomposition of 5-methyltetrahydrofolate may also contribute to the observed inhibitory effect of nitrites. It should be mentioned however, that decomposition of vitamin B12 caused by nitrites proceeds faster than that of the folate coenzyme (4). In fact it has been suggested that NOi ion, the product of nitrites decomposition in water, rather than nitrites themselves may be responsible for inactivation of the cofactors involved in methionine synthesis. Formation of nitrito cobalamin from methyl cobalamin as well as displacement of the methyl group from 5 N position of methyltetrahydrofolate have been postulated (4).
Alkyl nitrites were extremely toxic to the mice when applied in high concentration. The observed oxidation of hemoglobin to methemoglobin was probably responsible for their toxic effect. When nitrites were given to the mice in lower concentrations no effect of the drugs on methionine synthase activity in the liver or kidney could be detected. The most probable explanation of this observation is the assumption that nitrites rapidly reacted with hemoglobin to form methemoglobin and did not reach either the liver or kidney. Therefore, we conclude, that alkyl nitrites although inhibit methionine synthase in vitro do not act specifically on methionine synthase when applied in vivo and cannot be used as alternative to nitrous oxide in producing vitamin B12 and folate deficiency.
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